Comparative effectiveness of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on noninvasive indices of hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus. Επικοινωνία Submitted by Στέργιος Πολύζος on Τρί, 11/24/2020 - 11:40
